TECELRA Receives Full FDA Approval, Expands Access to Adolescents with Synovial Sarcoma
US WorldMeds® announced that the U.S. Food and Drug Administration has granted full approval to TECELRA® (afamitresgene autoleucel), with an expanded indication that now includes eligible patients as young as 12 years old. The therapy, which received its original accelerated approval in August 2024, remains…
11 Leading Oncologists and Researchers Unite to Accelerate Progress for Synovial Sarcoma Patients PHILADELPHIA [June 22, 2026] The Synovial Sarcoma Foundation (SSF) today announced the formation of its Medical Advisory Board, bringing together 11 internationally recognized clinicians and researchers to serve as the central coordinating…
Breaking Down Synovial Sarcoma’s Defenses: A study on Immune Evasion and Targeted Treatment
A landmark study from Jerby-Arnon, Neftel, Shore, and colleagues at the Broad Institute of Harvard and MIT, Massachusetts General Hospital, Dana-Farber Cancer Institute, and the University of Lausanne used single-cell RNA sequencing to profile 16,872 individual cells from 12 human synovial sarcoma tumors – one…
Tumor Board Continues to Grow with New Members to Advance Breakthrough Treatments for Synovial Sarcoma Patients
We are proud to share that the Tumor Board now includes 42 participating institutions, strengthening our collective expertise and reach.…
Synovial Sarcoma Foundation Celebrates Groundbreaking Achievement by Rachel Dr. Hurly
The Synovial Sarcoma Foundation is proud to announce a significant milestone in pediatric cancer research: Dr. Rachel Hurly, a dedicated…
Callan Spence: Survivor. Driver. Relentless Advocate.
Callan Spence isn’t waiting for progress—he’s chasing it down at full speed. At 20 years old, Callan is already a…
Inaugural Synovial Sarcoma Conference
On March 1, CHOP, in collaboration with Penn Medicine and the Synovial Sarcoma Foundation, hosted the first-ever national virtual conference…
The Synovial Sarcoma Foundation Surpasses $2 Million in Research Funding
Thanks to the generosity of donors and supporters, the Fund has now raised over $2 million, accelerating research initiatives at…
First-Ever Synovial Sarcoma Conference to Bring Together Patients, Researchers, and Experts in a Landmark Event
PHILADELPHIA, PA, UNITED STATES, February 20, 2025 — The Synovial Sarcoma Foundation is proud to announce that Children’s Hospital of Philadelphia…
Synovial Sarcoma Registry Reaches New Milestone
The Synovial Sarcoma Registry, launched in partnership with the Children’s Hospital of Philadelphia (CHOP), continues to grow as a critical…
Black Flag Sarcoma Race Team Takes the Track for Awareness
The Black Flag Sarcoma Race Team is shifting into high gear, using motorsports as a platform to raise awareness for…
Synovial Sarcoma Tumor Board Gains Widespread Adoption
The Synovial Sarcoma Tumor Board, funded by the Spence Family Synovial Sarcoma Foundation, has become an essential collaborative hub for…
